1 INTRODUCTION

    1.1 Study Objectives
    1.2 Market Definition

        1.2.1 Inclusions and Exclusions

    1.3 Study Scope

        1.3.1 Years Considered

    1.4 Currency Considered
    1.5 Stakeholders

2 MARKET OVERVIEW

    2.1 Introduction
    2.2 Market Dynamics

        2.2.1 Drivers

            2.2.1.1 Expanding companion animal population  and pet ownership
            2.2.1.2 Growing concerns about infectious  zoonotic diseases
            2.2.1.3 Rising awareness initiatives by  government and animal
                    welfare  organizations
            2.2.1.4 Increasing adoption of pet insurance and  high animal
                    healthcare expenditure

        2.2.2 Restraints

            2.2.2.1 Rising pet care costs
            2.2.2.2 Restrictions on Use of parasiticides for  food-producing
                    animals

        2.2.3 Opportunities

            2.2.3.1 Technological advancements and product  launches
            2.2.3.2 High growth potential in emerging  economies
            2.2.3.3 Surging number of veterinary  practitioners in developed
                    markets

        2.2.4 Challenges

            2.2.4.1 Growing resistance to parasiticides
            2.2.4.2 Diversity in parasite species

    2.3 Industry Trends

        2.3.1 Rise in Pet Ownership, Humanization of Pets, and  Increased Focus
              on Pet Wellness Programs
        2.3.2 Rising Use of Diagnostics and Wearable Technology  for Early
              Detection

    2.4 Technology Analysis

        2.4.1 Key Technologies

            2.4.1.1 Topical nanomedicine
            2.4.1.2 Biologic therapies

        2.4.2 Complementary Technologies

            2.4.2.1 Phototherapy
            2.4.2.2 Hydrotherapy

        2.4.3 Adjacent Technologies

            2.4.3.1 Telemedicine platforms
            2.4.3.2 Wearable devices

    2.5 Porter’s Five Forces Analysis

        2.5.1 Competitive Rivalry

            2.5.1.1 Established players
            2.5.1.2 Continuous innovation

        2.5.2 Bargaining Power of Buyers

            2.5.2.1 Consolidated veterinary groups
            2.5.2.2 Demand for affordable solutions

        2.5.3 Bargaining Power of Suppliers

            2.5.3.1 Specialized raw materials
            2.5.3.2 Quality compliance

        2.5.4 Threat of Substitutes

            2.5.4.1 Limited alternatives
            2.5.4.2 Specialized treatments

        2.5.5 Threat of New Entrants

            2.5.5.1 High R&D costs
            2.5.5.2 Regulatory requirements

    2.6 Patent Analysis

        2.6.1 Patent Publication Trends for Veterinary  Dermatology Market
        2.6.2 Insights: Jurisdiction and Top Applicant Analysis

    2.7 Trade Analysis

        2.7.1 Import and Export Scenario for Veterinary  Dermatology Products

    2.8 Reimbursement Analysis
    2.9 Key Conferences and Events
    2.10 Unmet Needs/End User Expectations in Veterinary  Dermatology Market
    2.11 Impact of Generative Ai on Veterinary Dermatology Market
    2.12 Ecosystem Analysis
    2.13 Supply Chain Analysis
    2.14 Value Chain Analysis
    2.15 Adjacent Markets for Veterinary Dermatology Market
    2.16 Trends/Disruptions Impacting Customer Business
    2.17 Investment and Funding Scenario

3 COMPETITIVE LANDSCAPE

    3.1 Overview
    3.2 Key Player Strategy/Right to Win
    3.3 Revenue Analysis of Key Players in Veterinary Dermatology  Market
        (2020–2024)
    3.4 Market Share Analysis, 2024

        3.4.1 Ranking of Key Market Players, 2024

    3.5 Company Evaluation Matrix: Startups/SMEs, 2024

        3.5.1 Progressive Companies
        3.5.2 Responsive Companies
        3.5.3 Dynamic Companies
        3.5.4 Starting Blocks
        3.5.5 Competitive Benchmarking: Startups/SMEs, 2024

    3.6 Brand/Product Comparison
    3.7 R&D Expenditure of Key Players
    3.8 Company Valuation and Financial Metrics

        3.8.1 Company Valuation
        3.8.2 Financial Metrics

    3.9 Competitive Scenario

        3.9.1 Product Approvals/Launches
        3.9.2 Deals
        3.9.3 Expansions
        3.9.4 Other Developments

4 COMPANY PROFILES

    4.1 VETRIMAX VETERINARY PRODUCTS (US)

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 VIVALDIS (INDIA)

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 MEDFLYVET (INDIA)

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 PET PERK(INDIA)

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 VEKO CARE PVT. LTD. (INDIA)

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 VETBIOTEK, INC. (US)

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 POSH SOCIETE SDN. BHD. (MALAYASIA)

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments

    4.8 VETNIQUE (US)

        4.8.1 Business overview
        4.8.2 Products/Solutions/Services offered
        4.8.3 Recent developments

    4.9 BIVETY BIOSCIENCES PRIVATE LIMITED (INDIA)

        4.9.1 Business overview
        4.9.2 Products/Solutions/Services offered
        4.9.3 Recent developments